Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02733926
Other study ID # HelsinkiU1
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 2016
Est. completion date December 2019

Study information

Verified date July 2019
Source Helsinki University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effect of vegetation cover on certain Interleukin-10 and immunoglobulinE (IgE) among children (3-5 y old). Children will either be in a kindergarten that does not have forest floor and agricultural land in the backyards, or alternatively they will be in a kindergarten that does have forest floor and agricultural land in the backyards.


Description:

High vegetation cover is assumed to change immunoglobulinE (IgE) and interleukin-10 concentrations in blood serum. Children living in high-green kindergarten are compared with those kindergarten living utilizing backyards with a low-green cover.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date December 2019
Est. primary completion date June 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 5 Years
Eligibility Inclusion Criteria:

- children living in study kindergartens

Exclusion Criteria:

- immune system deficiency, e.g. HIV-infection

- a drug decreasing immune system response, e.g. oral corticosteroid

- immune system disorder that affects immune response, e.g. rheumatoid

- colitis ulcerosa, Crohn disease, diabetes

- cancer

- age less than 3 or more than 5

- born outside Finland

- intellectual disability

Study Design


Intervention

Other:
Adding of vegetation into the backyards of kindergarten
Living plants are transferred into the backyards of kindergartens. This is assumed to affect the measured variables of children.

Locations

Country Name City State
Finland Helsinki University Lahti Häme

Sponsors (3)

Lead Sponsor Collaborator
Helsinki University Tampere University, Tampere University of Technology

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Other Associations between IL-10 and stool commensal microbiota Associations between serum plasma cytokine IL-10 and gut microbiota changes are related to intervention. Bacterial communities are related to immune response in one or more arms. 28 days
Other Associations between IL-17 and stool commensal microbiota Associations between serum plasma IL-17 and gut microbiota changes are related to intervention. Bacterial communities are related to immune response in one or more arms. 28 days
Other Associations between TGF-beta and stool commensal microbiota Associations between serum plasma TGF-beta and gut microbiota changes are related to intervention. Bacterial communities are related to immune response in one or more arms. 28 days
Other Associations between IL-10: IL-17 ratio and stool commensal microbiota Associations between serum plasma IL-10: IL-17ratios and gut microbiota changes are related to intervention. Bacterial communities are related to immune response in one or more arms. 28 days
Other Associations between TGF-beta: IL-17 ratio and stool commensal microbiota Associations between serum plasma TGF-beta: IL-17 ratio and gut microbiota changes are related to intervention. Bacterial communities are related to immune response in one or more arms. 28 days
Primary Diversity of Gammaproteobacteria on skin. Diversity of skin Gammaproteobacteria is higher in intervention arm compared to control arm and similar compared to nature-oriented arm after 28-day intervention. It will be measured at baseline and after 28-day intervention. 28 days
Secondary TGF-beta change in serum plasma An increase in TGF-beta in intervention arm but not in control arm at the end of the 28 days intervention 28 days
Secondary TGF-beta: IL-17A ratio in serum plasma An increase in TGF-beta: IL17A ratio in intervention arm but not in control arm at the end of the 28 days intervention 28 days
Secondary IL-10 change in serum plasma An increase in IL-10 in intervention arm but not in control arm at the end of the 28 days intervention 28 days
Secondary IL-17A change in serum plasma A decrease in IL-17A in intervention arm but not in control arm at the end of the 28 days intervention 28 days
Secondary Skin bacterial community changes at phylum level Diversity of skin bacterial phyla, particularly Proteobacterial community, is higher in intervention arm compared to control arm. Proteobacterial community was associated with the coverage of green land cover in an earlier study. In addition, it was different in atopic and non-atopic study subjects in an earlier study. Diversity is measured as Shannon diversity index, Multivariate Homogeneity of Group Dispersions and the number of taxa (richness). 28 days
Secondary Skin bacterial community changes at class level Diversity of skin bacterial classes is higher in intervention arm compared to control arm. Diversity of skin bacterial classes is higher in intervention arm compared to control arm. Other community changes include changes in relative abundance, richness and in community composition. If community changes are found, the same difference is searched for in the comparison of surface soil microbiota of intervention versus standard daycare yards. Diversity is measured as Shannon diversity index, Multivariate Homogeneity of Group Dispersions and the number of taxa (richness). 28 days
Secondary Skin bacterial community changes at order level Order level diversity is higher in intervention arm than control arm (in standard daycares). Other community changes include changes in relative abundance, richness and in community composition. If community changes are found, the same difference is searched for in the comparison of surface soil microbiota of intervention versus standard daycare yards. 28 days
Secondary Skin bacterial community changes at family level are higher in intervention than control arm If differences are found, it will be checked if diversity of one or more skin bacterial families is related to soil bacterial diversity. Diversity is measured as Shannon diversity index, Multivariate Homogeneity of Group Dispersions and the number of taxa (richness). 28 days
Secondary Skin bacterial community changes at genus level Diversity of skin bacterial genera is related to arms, i.e. higher in intervention arm. If differences are found, it will be checked if these occur also in soil bacterial diversity. Diversity is measured as Shannon diversity index, Multivariate Homogeneity of Group Dispersions and the number of taxa (richness). 28 days
Secondary Stool bacterial community changes at phylum level Community composition of gut bacterial phyla are different between arms. Other changes include changes in relative abundance, richness and diversity. 28 days
Secondary Stool bacterial community changes at class level Community composition of gut bacterial classes are different between arms. Other changes include changes in relative abundance, richness and diversity. 28 days
Secondary Stool bacterial community changes at order level Community composition of gut bacterial orders are different between arms. Other changes include changes in relative abundance, richness and diversity. 28 days
Secondary Stool bacterial community changes at family level Community composition of gut bacterial families, particularly Ruminococcaceae, is different between arms. Ruminococcaceae contain taxa associated with the production of short chain fatty acids, such as butyrate. Other changes include changes in relative abundance, richness and diversity. 28 days
Secondary Gut Faecalibacterium community changes Community composition of gut Faecalibacterium is different between arms. Faecalibacterium has been associated with gut health and low incidence of certain immune mediated diseases. 28 days
Secondary Associations between serum plasma TGF-beta and skin microbiota changes change in the cytokine will be separately compared with changes in bacterial diversity on skin 28 days
Secondary Associations between serum plasma IL-10 and skin Gammaproteobacterial microbiota changes change in the cytokine will be separately compared with changes in Gammaproteobacterial diversity on skin 28 days
Secondary Associations between serum plasma IL-17 and skin Gammaproteobacterial microbiota changes change in the cytokine will be separately compared with changes in Gammaproteobacterial diversity on skin 28 days
Secondary Interleukin-10 : interleukin-17A ratio in serum plasma An increase IL-10: IL-17A ratio in each arm at the end of the 28 day intervention will be examined 28 days